CordenPharma Caponago Announces Successful Approval of New Sterile Injectable Facility
CordenPharma recently announced the completion and approval of its aseptic filling line in CordenPharma Caponago (IT) by the Italian AIFA for clinical and commercial supply. This addition to the existing terminal sterilization capabilities of the manufacturing facility will support customer development and commercial programs by providing expert service in aseptic filling of liquid and lyophilized vials and prefilled syringes. The project was initiated in 2014, when CordenPharma had experienced an increasing demand from its customers in this market segment – in particular as it relates to the fully integrated supply of injectables together with peptide APIs.
“This new investment in the aseptic development capacities of CordenPharma Caponago strengthens our Injectable Platform and positions us as a fully integrated CDMO. Furthermore, it is a testament to our overall commitment in responding to customers’ needs,” said Ernesto Petroselli, President of CordenPharma International.
The expansion, which complements the already existing sterile capability at the site and in CordenPharma Latina (IT), is an additional step in the ongoing capacity expansion process that CordenPharma continues to pursue. Their aim is to supply complete injectable manufacturing services spanning development to commercial scale, including integrated peptide and oligonucleotide manufacturing capabilities.
CordenPharma, a pharmaceutical brand of International Chemical Investors Group (ICIG), is a full-service partner in the Contract Development & Manufacturing (CDMO) of APIs, Drug Products, and associated Packaging Services. Through a network of fully inspected cGMP facilities across Europe and the US organized under five technology platforms – Peptides, Lipids & Carbohydrates, Injectables, Highly Potent & Oncology, Small Molecules, and Antibiotics – CordenPharma experts translate complex ideas at any stage of development into high-value products. For more information, visit www.cordenpharma.com/contact-us/.
CordenPharma Caponago, one of multiple CordenPharma facilities across Europe and the US, specializes in the formulation and packaging of parenteral dosage forms, sterile emulsion technology, aseptic-filling of liquid and lyophilized vials, prefilled syringes and the distribution of clinical trial medications. For more information, visit www.cordenpharma.com/facilities/caponago/.
Total Page Views: 1224
